Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisJulian D. Gillmore, Philip N. Hawkins, Geoffrey B. Johnson et al.|Circulation|2016Cited by 2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo García‐Pavía, Aleš Linhart, Claudio Rapezzi et al.|European Heart Journal|2021Cited by 1.1k
Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac AmyloidosisImran S. Syed, Martha Grogan, James F. Glockner et al.|JACC. Cardiovascular imaging|2010Cited by 544
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D. Gillmore, Jonathan C. Fox, Daniel P. Judge et al.|New England Journal of Medicine|2024Cited by 453
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, Mathew S. Maurer, John L. Berk et al.|New England Journal of Medicine|2024Cited by 356